Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001995601-24-000002·Damora Therapeutics, Inc.
Schedule 13G ownership disclosure
GALECTO INC
Common Stock · CUSIP: 36322Q107
Event date: 2023-12-31
- Filing-level shares
- 2,060,000.00
- Percent of class
- 7.6%
- Otto Erik
Shares: 2,060,000.00 · Class: 7.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001995601-24-000002
- Form type
- SCHEDULE 13G/A
- Filer
- Damora Therapeutics, Inc.
- CIK
- CIK 1800315
- Filed
- Feb 09, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership